Skip the clinic: could a smartphone survey replace your post-surgery eye check?

NCT ID NCT04235803

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether a telemedicine follow-up — a simple online survey with photos and a vision check — can safely replace the first in-person visit after low-risk eyelid procedures like droopy eyelid repair or skin cancer removal. Adults undergoing these surgeries will either have a standard clinic visit or complete a remote form using their own device. The goal is to see if telemedicine cuts down on patient burden while keeping satisfaction and safety high.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
telemedicine follow-up via a remote survey (REDCap) that collects history, photographs, and vision measurement
What this could lead to
If it works, this could allow patients to skip an in-person post-op visit after low-risk eyelid surgery, saving time and travel.
What could go wrong
This is a small, single-center trial. Telemedicine may miss complications that an in-person exam would catch, and results may not apply to higher-risk procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLEPHAROPTOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of California, San Francisco

    San Francisco, California, 94143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.